Article Text

Download PDFPDF
Variant Creutzfeldt-Jakob Disease
  1. Andrea Lowman,
  2. Richard Knight,
  3. James Ironside
  1. The National CJD Surveillance Unit, Western General Hospital, Edinburgh, EH4 2XU, UK. E-mail: Andrea.Lowman{at}ed.ac.uk

Abstract

INTRODUCTION

Creutzfeldt–Jakob Disease (CJD) has been the focus of much attention in recent years due to the identification of a new variant now known as variant CJD (vCJD). Experimental evidence has shown that vCJD is due to human infection with the causative agent of Bovine Spongiform Encephalopathy (BSE), which was epidemic in UK cattle in the 1980s and early 1990s. Although vCJD remains rare, its existence has many implications. Clinicians have to face many questions from patients, relatives and other health care professionals. This review aims to present some of the scientific background, help health care professionals recognize the typical clinical picture and thus aid diagnosis.

CJD is a human transmissible spongiform encephalopathy (TSE). Uniquely, it is a disease that exists in sporadic, inherited and infectious forms. It is a rare, invariably fatal neurodegenerative disease that can be difficult to diagnose during life, and neuropathological examination of the brain

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Other content recommended for you